HUIDAGENE THERAPEUTICS RECEIVES FDA RARE PEDIATRIC DISEASE DESIGNATION FOR HG004 TO TREAT INHERITED BLINDNESS
/PRNewswire/ -- HuidaGene Therapeutics (辉大基因,"HuidaGene"), a clinical-stage biotechnology company focused on developing CRISPR-based programmable genomic...
Source: prnewswire.com